Nephrogen Inc.
Biotechnology company · New York, United States
Nephrogen Inc. is a biotechnology company headquartered in New York, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $325,000 in total, most recently in 2023.
nephrogenbiotech.comProfile compiled from public records. Is this your company? Request a correction or update
Nephrogen at a glance
Typebiotechnology company
HeadquartersNew York, United States
Employees (self-reported, 2023)5
What does Nephrogen do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $325,000 in total (2023). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.
Frequently asked questions about Nephrogen
Where is Nephrogen headquartered?
Nephrogen Inc. is headquartered in New York, United States.
What does Nephrogen do?
Nephrogen Inc. is a biotechnology company.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences